​

BioXcel Therapeutics (BTAI) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

BioXcel Therapeutics Revenue Highlights

Latest Revenue (Y)

$2.27M

Latest Revenue (Q)

$120.00K

BioXcel Therapeutics Revenue by Period

BioXcel Therapeutics Revenue by Year

DateRevenueChange
2024-12-31$2.27M64.20%
2023-12-31$1.38M268.00%
2022-12-31$375.00K100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31--

BioXcel Therapeutics generated $2.27M in revenue during NA 2024, up 64.20% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

BioXcel Therapeutics Revenue by Quarter

DateRevenueChange
2025-06-30$120.00K-28.57%
2025-03-31$168.00K-54.10%
2024-12-31$366.00K71.03%
2024-09-30$214.00K-80.62%
2024-06-30$1.10M89.69%
2024-03-31$582.00K54.79%
2023-12-31$376.00K10.26%
2023-09-30$341.00K-25.38%
2023-06-30$457.00K121.84%
2023-03-31$206.00K-13.45%
2022-12-31$238.00K73.72%
2022-09-30$137.00K100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$0.02100.00%
2020-09-30$0.01100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

BioXcel Therapeutics generated $120.00K in revenue during Q2 2025, up -28.57% compared to the previous quarter, and up 20.62% compared to the same period a year ago.

BioXcel Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
ADAPAdaptimmune Therapeutics$178.03M$7.29M
KPTIKaryopharm Therapeutics$145.24M$37.93M
MRSNMersana Therapeutics$40.50M$3.06M
CELUCelularity$22.77M$18.13M
BTAIBioXcel Therapeutics$2.27M$120.00K
EVAXEvaxion Biotech$73.11K$50.88K
INMBINmune Bio$14.00K$50.00K
NRXPNRx Pharmaceuticals--
SNTISenti Biosciences--
TPSTTempest Therapeutics--
ACRVAcrivon Therapeutics--

BTAI Revenue FAQ

What is BioXcel Therapeutics’s yearly revenue?

BioXcel Therapeutics's yearly revenue for 2024 was $2.27M, representing an increase of 64.20% compared to 2023. The company's yearly revenue for 2023 was $1.38M, representing an increase of 268.00% compared to 2022. BTAI's yearly revenue for 2022 was $375K, representing an increase of 100.00% compared to 2021.

What is BioXcel Therapeutics’s quarterly revenue?

BioXcel Therapeutics's quarterly revenue for Q2 2025 was $120K, a -28.57% decrease from the previous quarter (Q1 2025), and a -89.13% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $168K, a -54.10% decrease from the previous quarter (Q4 2024), and a -71.13% decrease year-over-year (Q1 2024). BTAI's quarterly revenue for Q4 2024 was $366K, a 71.03% increase from the previous quarter (Q3 2024), and a -2.66% decrease year-over-year (Q4 2023).

What is BioXcel Therapeutics’s revenue growth rate?

BioXcel Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 504.27%, and for the last 5 years (2020-2024) was 0%.